Fig. 1: Selected nucleotide and nucleoside analogs (NAs) and C2′-modification methods.
From: Discovery and substrate specificity engineering of nucleotide halogenases
a Halogenated NAs for clinical use. b Chemical method for C2′-modification of nucleoside analogs. c AdaV enables the direct C2′-halogenation of dAMP.
